Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
08/2005
08/31/2005EP1568355A1 N-alkylhydroxilated secondary paraphenylenediamine which is ortho- and/or meta substituted, composition for dying keratinous fibres comprising this paraphenylenediamine, methods based on this composition and uses.
08/31/2005EP1070048B1 Calcilytic compounds
08/31/2005EP1069894B1 Spisulosine compounds having antitumour activity
08/31/2005EP0989973B1 Chalcones having antiproliferative activity
08/31/2005CN1662486A Process for chlorinating tertiary alcohols
08/31/2005CN1660776A Compound of aroma dihydroxy diamines and preparation method
08/31/2005CN1660773A Tertiary p-phenylenediamines, dyes compositions comprising thereof, and dyeing processes using the same
08/31/2005CN1216855C Crystal polymorphism of aminoethylphenoxyacetic acid derivatives
08/31/2005CN1216854C Ether amide production method
08/30/2005US6936077 1,3-diamino-4-(aminomethyl)—benzene derivatives and colorants containing the said compounds
08/30/2005CA2202879C Calcium receptor-active compounds
08/30/2005CA2195372C A method of preparing the enantiomers of o-demethyltramadol
08/30/2005CA2119052C Enantioselective process for the preparation of levobunolol
08/25/2005WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use
08/25/2005WO2005077892A1 Calcilytic compounds
08/25/2005WO2005077886A1 Calcilytic compounds
08/25/2005US20050187407 High load polystyrene-polyethylene glycol-like resins having excellent swelling; polyoxyethylene glycol-like chain comprises [2-(2-aminoethoxy)ethoxy]-acetic acid (AEEA); solid phase peptide synthesis
08/25/2005US20050187399 Asymmetric epoxidation of cinnamyl alcohol; oxidation, cyclization in base; amination, sulfonation, silylation, deblocking; enantioselectivity; chemical intermediates
08/25/2005US20050187345 Living olefin polymerization processes
08/25/2005US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis
08/25/2005CA2555884A1 Amino-substituted tricyclic derivatives and methods of use
08/24/2005EP1565500A2 Acrylic polymers containing pendant primary carbamate groups, a method of making said polymers, and curable coating compositions containing said polymers
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1216036C Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine
08/23/2005US6933411 Adhesive; low temperature bonding strength
08/23/2005US6933390 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
08/23/2005CA2097148C M-phenylenediamine couplers and oxidative hair dye compositions containing same
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005075408A1 L-(-)-moprolol l-(+)-tartrate
08/18/2005WO2003101931A3 Preparation of 4-(n, n-disubstitutedamino) butyraldehyde acetals
08/18/2005US20050182131 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
08/18/2005US20050182081 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
08/16/2005US6930205 Process for preparing aminostilbene derivatives
08/16/2005US6929872 Organic electroluminescent devices
08/16/2005CA2197616C The preparation and use of (3-alkoxy-phenyl) magnesium chlorides
08/11/2005WO2005072246A2 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
08/11/2005WO2005051888A3 Diphenylamine derivatives
08/11/2005US20050176899 Mannich bases from isolated amine adducts
08/11/2005US20050176790 Pharmaceutical salts
08/11/2005CA2554163A1 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
08/10/2005EP1561744A2 Amine derivatives, process for producing the same and their use as antimycotic agent
08/10/2005EP1560864A1 Carbamate functional materials, a method of making said materials, and curable coating compositions containing said materials
08/10/2005EP1560807A1 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652767A Adduct of topiramate and tramadol hydrochloride and uses thereof
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1213994C Process for prepn. of phenethylamine derivatives
08/09/2005CA2093084C Ferrocenyl diphosphines as ligands for homogeneous catalysts
08/04/2005WO2005071139A1 Composition and method for forming phosphate containing surfaces on components in hydrocarbon combustion zones
08/04/2005WO2005070873A2 Alkoxylated amines
08/04/2005WO2005070869A1 Selective hydrogenation of nitrogen containing aromatics
08/04/2005US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders
08/04/2005US20050170966 Hydroxy group and amine oxide, amine, amine salt or quaternary ammonium functionalized polyglycols; emulsifiers, wetting agents, dispersants, thickeners or solubilizers; water soluble formulations; agrochemicals, cosmetics, fabric softeners
08/04/2005CA2554333A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/03/2005EP1559707A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
08/03/2005EP1559706A1 Aromatic amine derivative and organic electroluminescent element employing the same
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558238A2 Beta-hydroxyphenylaldylamines and their use for treating glaucoma
08/03/2005EP1558222A2 Pharmaceutical compositions containing venlafaxine
08/03/2005CN1649826A 5-amino-1-pentene-3-ol substituted derivatives
08/03/2005CN1213127C Organic electroluminescence device and phenylenediamine derivative
08/03/2005CN1212834C Fluoxetine enteric soluble micro-capsule
08/02/2005US6924393 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
08/02/2005US6924391 Antiinflammatory agents; antitumor agent
08/02/2005US6924315 Surfactants or wetting agents comprising polyoxyalkylene amines such as N,N'-di[2-hydroxy-3-(2-ethyl)hexyloxypropyl]-N,N'-di(1-deoxyglucityl)-1,6-diaminohexane
08/02/2005US6924314 Compounds for the treatment of metabolic disorders
07/2005
07/28/2005WO2005068403A2 Method for selective reduction of aromatic compounds
07/28/2005US20050165257 using said inositol derivative as the intermediate; low cost in a safe process
07/28/2005US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
07/28/2005US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
07/28/2005US20050164872 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
07/28/2005US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
07/28/2005DE10359154A1 Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I Process for the preparation of venlafaxine, and venlafaxine hydrochloride Form I
07/28/2005CA2552438A1 Method for selective reduction of aromatic compounds
07/27/2005EP1556335A1 Bis-alkylbenzylamines
07/27/2005EP1556029A2 Thiomolybdate analogues and uses thereof
07/27/2005CN1646594A Mannich bases from isolated amine adducts
07/27/2005CN1646478A 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
07/27/2005CN1646476A Method for preparing combretastatins
07/27/2005CN1212310C Propanol amine kind ether compound synthesized using paeonol as mother body and its derivative
07/27/2005CN1212309C Propanol amine kind ether compound synthesized using paeonol as mother body and its derivative
07/26/2005US6921840 SPECT imaging agents for serotonin transporters
07/26/2005CA2256579C Process for the bleaching of chemical pulp
07/21/2005US20050159634 Addition/condensation polymerization
07/21/2005US20050159625 For use in auto clear coat and primer
07/21/2005US20050159519 Phenylenediamine derivative, production method thereof and antioxidant for rubber using it as effective constituent
07/21/2005US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
07/21/2005DE102004060894A1 Ionische Flüssigkeiten und Verfahren zu ihrer Herstellung Ionic liquids and methods for their preparation
07/20/2005EP1268396B1 Diphenyl ether compounds useful in therapy
07/20/2005EP1185493B1 Quinones for treatment of diseases
07/20/2005CN1642638A Catalysts and method for the production of amines
07/20/2005CN1640867A Venlafaxine and its salt preparing method
07/20/2005CN1211359C New phenalkyoxy-phenyl derivatives
07/19/2005US6919482 A 1,4-bis(N-(2-(4-hydroxy-3-hydroxymethylphenyl) -2-hydroxyethyl)amino)-cyclohexane or alkyl-cyclohexane or -pyrazine derivatives; treating respiratory diseases disorders, asthma, bronchitis, nervous system injury
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 140